DrugPatentWatch Database Preview

Patent: 9,877,962

« Back to Dashboard

Summary for Patent: 9,877,962

Title:	Piperazinyl derivatives for the treatment of cancer
Abstract:	Piperazinyl derivatives of formula (I) and their use as a drug, particularly for the treatment of cancer, are disclosed. Also disclosed are pharmaceutical compositions comprising the piperazinyl derivatives, and methods for synthesizing the piperazinyl derivatives.
Inventor(s):	Carniato; Denis (Marcoussis, FR), Briand; Jean-Francois (Saclay, FR), Gutmann; Mathieu (Vaugrigneuse, FR), Busnel; Olivier (Allennes les Marais, FR), Bougeret; Cecile (Nevers, FR), Deprez; Benoit (Lille, FR), Jaillardon; Karine (Saint Michel s/Orge, FR)
Assignee:	Pitty; Marc Henry (Boulogne-Billancourt, FR)
Application Number:	15/135,994
Patent Claims:	see list of patent claims

Details for Patent 9,877,962

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	RITUXAN	rituximab	Injection	103705	1997-11-26		2031-12-30
Genentech, Inc.	HERCEPTIN	trastuzumab	For Injection	103792	1998-09-25		2031-12-30
Genentech, Inc.	HERCEPTIN	trastuzumab	For Injection	103792	2017-02-10		2031-12-30
Eli Lilly And Company	ERBITUX	cetuximab	Injection	125084	2004-02-12		2031-12-30
Eli Lilly And Company	ERBITUX	cetuximab	Injection	125084	2007-03-28		2031-12-30
Genentech, Inc.	AVASTIN	bevacizumab	Injection	125085	2004-02-26		2031-12-30
Genentech, Inc.	PERJETA	pertuzumab	Injection	125409	2012-06-08		2031-12-30